PRODUCT USE IN UNAPPROVED INDICATION

This adverse event was reported 101229 times

These drugs are most commonly taken by patients reporting PRODUCT USE IN UNAPPROVED INDICATION:

# Drug Count
0 PREDNISONE 5398
1 RISPERIDONE 5069
2 GABAPENTIN 4593
3 METHOTREXATE SODIUM 4127
4 MYCOPHENOLATE MOFETIL 4098
5 METHOTREXATE 3706
6 CYCLOPHOSPHAMIDE 3675
7 ADAPALENE 3603
8 TACROLIMUS 3490
9 TACROLIMUS CAPSULES 3179
See all common drugs associated with PRODUCT USE IN UNAPPROVED INDICATION

PRODUCT USE IN UNAPPROVED INDICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METHOXSALEN 196 0.4261
1 DUVELISIB 93 0.2879
2 ETHIODIZED OIL 130 0.1903
3 BINIMETINIB 498 0.1739
4 ENCORAFENIB 494 0.1702
5 TENIPOSIDE 70 0.1651
6 TAFAMIDIS MEGLUMINE 225 0.1469
7 CEFTOLOZANE AND TAZOBACTAM 92 0.1409
8 FLIBANSERIN 42 0.1382
9 STIRIPENTOL 91 0.1377
See all drugs enriched for association with PRODUCT USE IN UNAPPROVED INDICATION